CHMP adopts positive opinions on two bevacizumab biosimilars

Published date02 February 2021
Subject MatterEU,Prescription Drugs,Biosimilars,Pharmaceutical Industry,European Medicines Agency (EMA)
Law FirmGoodwin

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT